Sales rise 27.36% to Rs 417.84 crore
Net profit of ERIS Lifesciences rose 1.08% to Rs 101.86 crore in the quarter ended December 2022 as against Rs 100.77 crore during the previous quarter ended December 2021. Sales rose 27.36% to Rs 417.84 crore in the quarter ended December 2022 as against Rs 328.07 crore during the previous quarter ended December 2021. ParticularsQuarter EndedDec. 2022Dec. 2021% Var.Sales417.84328.07 27 OPM %32.8437.10 -PBDT136.44125.86 8 PBT106.54108.98 -2 NP101.86100.77 1Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
